DOI: http://dx.doi.org/10.18203/2349-2902.isj20204692

Small bowel malignant tumor: a diagnostic dilemma, a case report and literature review

Mahmood A. Makhdoomi, Abdulaziz Almotlaq, Nader A. Tawfiq

Abstract


A 47 years old Saudi male was admitted to king Khalid hospital with complaints of constipation and abdominal distension. Abdominal examination showed as a case of intestinal obstruction. He was fully evaluated and was treated first conservatively, until all investigative study confirmed as huge small bowel dilatation (mainly jejunum). Exploratory laparotomy confirmed small bowel tumor and on histology an adenocarcinoma. The introduction, history and research paper will also be discussed in this report.


Keywords


Small bowel tumor, Small bowel adenocarcinoma, Jejunal tumor, Jejunal adenocarcinoma, Intestinal obstruction, Small bowel obstruction

Full Text:

PDF

References


Hamberger GE. Proempticum auspicale quo dissertantionem solemnen: indicit et de ruptura intestini duodeni disserit. Jena: Litteris Ritterianis, 1746:1.

Foerster G. Fibroid der muscularis des ileum. Virchows. Arch Pathol Anat. 1858;13:270.

Wesener F. Geirtrage zur casuistil der geschwulste i uebe.

Leichtenstern O. handbuch des speziellen pathologie und therapie. 1983;7(1).

Heurtaux A. Note sur les tumeurs benignes de L'intestin. Arch prov chir. 1890;8:701.

Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Cau Control. 2005;16:781-7.

Shack LG, Wood HE, Kang JY, Brewster DH, Quinn MJ, Maxwell JD et al. Small intestinal cancer in England and Wales and Scotland: time trends in incidence, mortality and survival. Aliment Pharmacol Ther. 2006;23:1297-1306.

SEER cancer statistics factsheets: small intestine cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/ststfacts/html/smint.html. Accessed on 9/7/2020.

Pan SY, Morrison H. Epidemiology of cancer of the small intestine. World J Gastrointest Oncol. 2011;3:33-42.

Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010;199:797-803.

Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101:518-26.

Hong SH, Koh YH, Rho SY, Byun JH, Oh ST, Im KW et al. Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome. Jpn J Clin Oncol. 2009;39:54-61.

Speranza G, Doroshow JH, Kummar S. Adenocarcinoma of the small bowel: changes in the landscape? Curr Opin Oncol. 2010;22:387-93.

Talamonti MS, Goetz LH, Rao S, Joehl RJ. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical managements. Arch Surg. 2002;137:564-70.

Horton KM, Fishman EK. The current status of multidetector row CT and three-dimensional imaging of the small bowel. Radiol Clin North Am. 2003;41:199-212.

Cronin CG, Scott J, Kambadakone A, Catalano OA, Sahani D, Blake MA et al. Utility of position emission tomography/CT in the evaluation of small bowel pathology. Br J Radiol. 2012;85:1211-21.

Zhang ZH, Qiu CH, Li Y. Different roles of capsule endoscopy and double-balloon enteroscopy in obscure small intestinal diseases. World J Gastroenterol. 2015;21:7297-7304.

Zaanan A, Costes L, Gauthier M, Malka D, Locher C, Mitry E et al. Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study. Ann Oncol. 2010;21:1786-93.

Apaicio T, Zaanan A, Svrcek M, Laurent P, Carrere N, Manfredi S et al. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Digest liver dis. 2014;46:97-104.

Ecker BL, McMillan MT, Datta J, Mamtani R, Giantonio BJ, Dempsey DT et al. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: a propensity score-matched analysis. Cancer. 2016;122:693-701.

Mizushima T, Tamagawa H, Mishima H, Ikeda K, Fujita S, Akamatsu H et al. The effects of chemotherapy on primary small bowel cancer: a retrospective multicenter observational study in Japan. Mol Clin Oncol. 2013;1:820-24.

Overman MJ, Varadhachary GR, Kopetz S, Adinin R, Lin E, Morris JS et al. PhaseII study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009;27:2598-2603.

Xiang XJ, Liu YW, Zhang L, Qiu F, Yu F, Zhan ZY et al. A phaseIIstudy of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocinoma. Anticancer Drugs. 2012;23:561-6.

De Dosso S, Molinari F, Martin V, Frattini M, Saletti P. Molecular characterization and cetuximab-based treatment in a patient with refractory small bowel adenocarcinoma. Gut. 2010;59:1587-8.

Zaaimi Y, Aparicio T, Laurent-Puig P, Taieb J, Zaanan A. Advanced small bowel adenocarcinoma: molecular characteristics and therapeutic perspectives. Clin Res Hepatol Gastroenterol. 2016;40:154-60.